icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
 
 
 
MULTIPLE DAILY DOSES OF MK-8591 AS LOW AS 0.25 MG ARE EXPECTED TO SUPPRESS HIV
 
 
  Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
 
Randolph P. Matthews, Deanne J. Rudd, Vanessa Levine, Sandra Zhang, Laura Sterling, Jay Grobler, Ryan Vargo, S. Aubrey Stoch, Marian Iwamoto
 
WEBCAST: http://www.croiwebcasts.org/console/player/37063?mediaType=slideVideo&&crd_fl=1&ssmsrq=1522781323018&ctms=5000&csmsrq=890
 

0305181

0305182

0305183

0305184

0305185

0305186